Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
689.7 INR | -0.39% | -0.70% | -13.70% |
May. 01 | Rossari Biotech's Consolidated Profit Climbs in FIscal Q4 | MT |
Apr. 30 | Transcript : Rossari Biotech Limited, Q4 2024 Earnings Call, Apr 30, 2024 |
Sales 2024 | 18.31B 219M | Sales 2025 * | 20.91B 251M | Capitalization | 38.1B 457M |
---|---|---|---|---|---|
Net income 2024 | 1.31B 15.67M | Net income 2025 * | 1.64B 19.72M | EV / Sales 2024 | 2.04 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 |
28.7
x | P/E ratio 2025 * |
23.1
x | Employees | 500 |
Yield 2024 * |
0.44% | Yield 2025 * |
0.38% | Free-Float | 31.68% |
Latest transcript on Rossari Biotech Limited
1 day | -0.39% | ||
1 week | -0.70% | ||
1 month | -7.95% | ||
3 months | -7.48% | ||
6 months | -4.52% | ||
Current year | -13.70% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 58 | 96-12-31 | |
Edward Menezes
FOU | Founder | 63 | 96-12-31 |
Ketan Sablok
DFI | Director of Finance/CFO | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 50 | 23-04-28 | |
Edward Menezes
FOU | Founder | 63 | 96-12-31 |
Founder | 58 | 96-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 689.7 | -0.39% | 93,937 |
24-05-30 | 692.4 | -0.50% | 29,273 |
24-05-29 | 695.9 | -0.04% | 27,979 |
24-05-28 | 696.2 | +0.41% | 50,231 |
24-05-27 | 693.3 | -0.18% | 64,481 |
Delayed Quote NSE India S.E., May 31, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.70% | 457M | |
+17.07% | 66.31B | |
-0.29% | 48.46B | |
+21.61% | 43.27B | |
+26.72% | 27.41B | |
+9.25% | 19.26B | |
+9.75% | 16.58B | |
-2.14% | 16.61B | |
-15.01% | 14.41B | |
-30.22% | 14.02B |
- Stock Market
- Equities
- ROSSARI Stock